Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002207.SZ
Valuation Bad
0%
Profitability n.A.
Fin. Growth Best
100%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -10.90 0.76 0.86
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -99.74 -4.61 1749.90
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -14.03 0.27 0.31
Cash -10.15 0.11 0.12
Capex 41.39 -0.01 -0.02
Free Cash Flow 188.74 0.03 0.01
Revenue -59.53 0.15 0.38
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 278.88 -0.23 0.06
Operating Margin 11240.91 -0.26 < 0.005
ROA -1606.22 -0.04 < 0.005
ROE -1498.55 -0.15 < 0.005
ROIC 3804.49 -0.07 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002207.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002207.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002207.SZ is permitted for members.